Funding for this research was provided by:
National Institute of Mental Health (K23MH118999)
National Institute of Allergy and Infectious Diseases (R01 AI121207)
Received: 1 May 2020
Accepted: 1 June 2020
First Online: 18 June 2020
Ethics approval and consent to participate
: The patient was consented for participation in the COVID-19 IMPACT biorepository study at Yale, approved by the Yale University Institutional Review Board, HIC#2000027690.
: The patient is aware of this case report submission and has provided written consent for this publication.
: The authors report no competing interests.